IL13 and systemic sclerosis: Associated with higher risk of progressive lung fibrosis and decline in lung capacity in SSc. High levels of IL-4 and IL-13 associated positively with presence of Scl-70 or anti-centromere antibodies and negatively with glucocorticoid treatment in SSc. Associated with active disease in SLE.